Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.1T | 1.1T | 994.6B | 1.1T |
Cost of revenue | 996.6B | 999.5B | 934.6B | 1.1T |
Gross profit | 94.1B | 101.3B | 60.1B | 54.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 52.5B | 45.8B | 45.3B |
Operating income | -97.4B | 44.4B | 11.8B | 6.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 7.6B | 9.3B | 9.4B | 7.3B |
Other income expense | — | — | — | — |
Pretax income | 43.4B | 35.1B | 3.5B | 8.1B |
Tax provision | 9.2B | 9.7B | 2.1B | 1.7B |
Net income | 34.2B | 25.4B | 1.4B | 6.3B |
Basic EPS | — | 12.0 | 0.7 | 3.0 |
Diluted EPS | — | 12.0 | 0.7 | 3.0 |
Basic average shares | — | 2.1B | 2.1B | 2.1B |
Diluted average shares | — | 2.1B | 2.1B | 2.1B |
EBITDA | 50.9B | 44.4B | 12.9B | 15.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |